Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000049.xml
Download PDF
Clin Colon Rectal Surg 2018; 31(06): 361-367
DOI: 10.1055/s-0038-1668106
DOI: 10.1055/s-0038-1668106
Review Article
Multidisciplinary Approach to the Management and Treatment of Anal Dysplasia
Further Information
Publication History
Publication Date:
02 November 2018 (online)
Abstract
The incidence of anal intraepithelial neoplasia (AIN) has been increasing over the years. AIN acts as a precursor lesion for anal squamous cell cancer. Factors leading to progression of AIN into malignancy are complex and involve grade of the lesion, human papillomavirus and HIV coinfection, as well as patient-related risk factors such as immunocompromised state and men who have sex with men. The multifaced aspects of this disease make its management challenging, as it involves several disciplines including pathology, primary care, infectious disease, and colorectal specialties. Each of these fields brings its own expertize to the management of AIN, and their collaborative, coordinated work culminates into best practice and optimized outcomes in the care of the AIN patient.
-
References
- 1 Nelson RA, Levine AM, Bernstein L, Smith DD, Lai LL. Changing patterns of anal canal carcinoma in the United States. J Clin Oncol 2013; 31 (12) 1569-1575
- 2 Silverberg MJ, Lau B, Justice AC. , et al; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012; 54 (07) 1026-1034
- 3 Ogunbiyi OA, Scholefield JH, Raftery AT. , et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 1994; 81 (03) 365-367
- 4 Medford RJ, Salit IE. Anal cancer and intraepithelial neoplasia: epidemiology, screening and prevention of a sexually transmitted disease. CMAJ 2015; 187 (02) 111-115
- 5 Chaves EB, Folgierini H, Capp E, von Eye Corleta H. Prevalence of abnormal anal cytology in women infected with HIV. J Med Virol 2012; 84 (09) 1335-1339
- 6 Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62 (01) 10-29
- 7 Watson AJ, Smith BB, Whitehead MR, Sykes PH, Frizelle FA. Malignant progression of anal intraepithelial neoplasia. ANZ J Surg 2006; 76 (08) 715-717
- 8 Scholefield JH, Castle MT, Watson NF. Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg 2005; 92 (09) 1133-1136
- 9 Crawshaw BP, Russ AJ, Stein SL. , et al. High-resolution anoscopy or expectant management for anal intraepithelial neoplasia for the prevention of anal cancer: is there really a difference?. Dis Colon Rectum 2015; 58 (01) 53-59
- 10 Goldstone SE, Johnstone AA, Moshier EL. Long-term outcome of ablation of anal high-grade squamous intraepithelial lesions: recurrence and incidence of cancer. Dis Colon Rectum 2014; 57 (03) 316-323
- 11 National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. JAMA 1989; 262 (07) 931-934
- 12 Carter PS, Sheffield JP, Shepherd N. , et al. Interobserver variation in the reporting of the histopathological grading of anal intraepithelial neoplasia. J Clin Pathol 1994; 47 (11) 1032-1034
- 13 Solomon D, Davey D, Kurman R. , et al; Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287 (16) 2114-2119
- 14 Darragh TM, Colgan TJ, Thomas Cox J. , et al; Members of the LAST Project Work Groups. The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol 2013; 32 (01) 76-115
- 15 Darragh TM, Colgan TJ, Cox JT. , et al; Members of LAST Project Work Groups. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med 2012; 136 (10) 1266-1297
- 16 Foust RL, Dean PJ, Stoler MH, Moinuddin SM. Intraepithelial neoplasia of the anal canal in hemorrhoidal tissue: a study of 19 cases. Hum Pathol 1991; 22 (06) 528-534
- 17 Fenger C, Nielsen VT. Precancerous changes in the anal canal epithelium in resection specimens. Acta Pathol Microbiol Immunol Scand [A] 1986; 94 (01) 63-69
- 18 Hanson IM, Armstrong GR. Anal intraepithelial neoplasia in an inflammatory cloacogenic polyp. J Clin Pathol 1999; 52 (05) 393-394
- 19 Snover DC. Maximizing the value of the endoscopist-pathologist partnership in the management of colorectal polyps and carcinoma. Gastrointest Endosc Clin N Am 2010; 20 (04) 641-657
- 20 Fernando M, Amarsekara LR. The pathologist and colorectal cancer. Ceylon Med J 1998; 43 (03) 167
- 21 Longacre TA, Kong CS, Welton ML. Diagnostic problems in anal pathology. Adv Anat Pathol 2008; 15 (05) 263-278
- 22 Wachter RM, Goldman L. The emerging role of “hospitalists” in the American health care system. N Engl J Med 1996; 335 (07) 514-517
- 23 Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 1999; 85 (08) 1686-1693
- 24 Möller C, Saksela E. Cancer of the anus and anal canal. Acta Chir Scand 1970; 136 (04) 340-348
- 25 Dewdney A, Rao S. Metastatic squamous cell carcinoma of the anus: time for a shift in the treatment paradigm?. ISRN Oncol 2012; 2012: 756591
- 26 Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA. ; Infectious Diseases Society of America. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2014; 58 (01) 1-10
- 27 Oon SF, Winter DC. Perianal condylomas, anal squamous intraepithelial neoplasms and screening: a review of the literature. J Med Screen 2010; 17 (01) 44-49
- 28 Cranston RD, Darragh TM, Holly EA. , et al. Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men. J Acquir Immune Defic Syndr 2004; 36 (04) 915-920
- 29 Ortoski RA, Kell CS. Anal cancer and screening guidelines for human papillomavirus in men. J Am Osteopath Assoc 2011; 111 (03) (Suppl. 02) S35-S43
- 30 D'Souza G, Rajan SD, Bhatia R. , et al. Uptake and predictors of anal cancer screening in men who have sex with men. Am J Public Health 2013; 103 (09) e88-e95
- 31 Salit IE, Lytwyn A, Raboud J. , et al. The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening. AIDS 2010; 24 (09) 1307-1313
- 32 Nahas CS, da Silva Filho EV, Segurado AA. , et al. Screening anal dysplasia in HIV-infected patients: is there an agreement between anal pap smear and high-resolution anoscopy-guided biopsy?. Dis Colon Rectum 2009; 52 (11) 1854-1860
- 33 Jay N, Berry JM, Hogeboom CJ, Holly EA, Darragh TM, Palefsky JM. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum 1997; 40 (08) 919-928
- 34 Shum J, Kelsberg G, Safranek S. Clinical inquiry: does qHPV vaccine prevent anal intraepithelial neoplasia and condylomata in men?. J Fam Pract 2015; 64 (09) 581-583
- 35 Palefsky JM, Giuliano AR, Goldstone S. , et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365 (17) 1576-1585
- 36 Deshmukh AA, Chhatwal J, Chiao EY, Nyitray AG, Das P, Cantor SB. Long-term outcomes of adding HPV vaccine to the anal intraepithelial neoplasia treatment regimen in HIV-positive men who have sex with men. Clin Infect Dis 2015; 61 (10) 1527-1535
- 37 Markowitz LE, Dunne EF, Saraiya M. , et al; Centers for Disease Control and Prevention (CDC). Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014; 63 (RR-05): 1-30
- 38 Kumar VM, Whynes DK. Explaining variation in the uptake of HPV vaccination in England. BMC Public Health 2011; 11: 172
- 39 Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine 2012; 30 (24) 3546-3556
- 40 Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009; 124 (10) 2375-2383
- 41 Tilston P. Anal human papillomavirus and anal cancer. J Clin Pathol 1997; 50 (08) 625-634
- 42 Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine 2006; 24 (Suppl. 03) S3 , 42–51
- 43 zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92 (09) 690-698
- 44 Woodworth CD, Notario V, DiPaolo JA. Transforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J Virol 1990; 64 (10) 4767-4775
- 45 Machalek DA, Poynten M, Jin F. , et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012; 13 (05) 487-500
- 46 Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177 (02) 361-367
- 47 Palefsky JM, Holly EA, Hogeboom CJ. , et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17 (04) 314-319
- 48 Piketty C, Darragh TM, Heard I. , et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004; 31 (02) 96-99
- 49 Piketty C, Darragh TM, Da Costa M. , et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003; 138 (06) 453-459
- 50 Palefsky JM, Holly EA, Efirdc JT. , et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005; 19 (13) 1407-1414
- 51 Steele SR, Varma MG, Melton GB, Ross HM, Rafferty JF, Buie WD. ; Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for anal squamous neoplasms. Dis Colon Rectum 2012; 55 (07) 735-749
- 52 Devaraj B, Cosman BC. Expectant management of anal squamous dysplasia in patients with HIV. Dis Colon Rectum 2006; 49 (01) 36-40
- 53 Bach DB. Missed diagnosis of colorectal carcinoma at barium enema examination. Radiology 1995; 194 (02) 580
- 54 Pineda CE, Berry JM, Jay N, Palefsky JM, Welton ML. High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience. Dis Colon Rectum 2008; 51 (06) 829-835 , discussion 835–837
- 55 Tramujas da Costa e Silva I, de Lima Ferreira LC, Santos Gimenez F. , et al. High-resolution anoscopy in the diagnosis of anal cancer precursor lesions in renal graft recipients. Ann Surg Oncol 2008; 15 (05) 1470-1475
- 56 Berry JM, Palefsky JM, Jay N, Cheng SC, Darragh TM, Chin-Hong PV. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum 2009; 52 (02) 239-247
- 57 Mathews WC, Sitapati A, Caperna JC, Barber RE, Tugend A, Go U. Measurement characteristics of anal cytology, histopathology, and high-resolution anoscopic visual impression in an anal dysplasia screening program. J Acquir Immune Defic Syndr 2004; 37 (05) 1610-1615
- 58 Lam JM, Hoch JS, Tinmouth J, Sano M, Raboud J, Salit IE. Cost-effectiveness of screening for anal precancers in HIV-positive men. AIDS 2011; 25 (05) 635-642
- 59 Project NATaA. NYS Guidelines Recommendations on Anal Pap Smears. National AIDS Treatment Advocacy Project, www.natap.org/2010/HIV/032510_01.htm
- 60 Wieland U, Brockmeyer NH, Weissenborn SJ. , et al. Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men. Arch Dermatol 2006; 142 (11) 1438-1444
- 61 Rosen T, Harting M, Gibson M. Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study. Dermatol Surg 2007; 33 (04) 427-431 , discussion 431–432
- 62 Richel O, Wieland U, de Vries HJ. , et al. Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men. Br J Dermatol 2010; 163 (06) 1301-1307
- 63 Graham BD, Jetmore AB, Foote JE, Arnold LK. Topical 5-fluorouracil in the management of extensive anal Bowen's disease: a preferred approach. Dis Colon Rectum 2005; 48 (03) 444-450
- 64 Allison RR, Sheng C, Cuenca R, Bagnato VS, Austerlitz C, Sibata CH. Photodynamic therapy for anal cancer. Photodiagn Photodyn Ther 2010; 7 (02) 115-119
- 65 Hamdan KA, Tait IS, Nadeau V, Padgett M, Carey F, Steele RJ. Treatment of grade III anal intraepithelial neoplasia with photodynamic therapy: report of a case. Dis Colon Rectum 2003; 46 (11) 1555-1559
- 66 Welbourn H, Duthie G, Powell J, Moghissi K. Can photodynamic therapy be the preferred treatment option for anal intraepithelial neoplasia? Initial results of a pilot study. Photodiagn Photodyn Ther 2014; 11 (01) 20-21
- 67 Margenthaler JA, Dietz DW, Mutch MG, Birnbaum EH, Kodner IJ, Fleshman JW. Outcomes, risk of other malignancies, and need for formal mapping procedures in patients with perianal Bowen's disease. Dis Colon Rectum 2004; 47 (10) 1655-1660 , discussion 1660–1661
- 68 Brown SR, Skinner P, Tidy J, Smith JH, Sharp F, Hosie KB. Outcome after surgical resection for high-grade anal intraepithelial neoplasia (Bowen's disease). Br J Surg 1999; 86 (08) 1063-1066
- 69 Goldstone SE, Hundert JS, Huyett JW. Infrared coagulator ablation of high-grade anal squamous intraepithelial lesions in HIV-negative males who have sex with males. Dis Colon Rectum 2007; 50 (05) 565-575
- 70 Chang GJ, Berry JM, Jay N, Palefsky JM, Welton ML. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum 2002; 45 (04) 453-458
- 71 Cleary RK, Schaldenbrand JD, Fowler JJ, Schuler JM, Lampman RM. Perianal Bowen's disease and anal intraepithelial neoplasia: review of the literature. Dis Colon Rectum 1999; 42 (07) 945-951
- 72 Goldstone RN, Goldstone AB, Russ J, Goldstone SE. Long-term follow-up of infrared coagulator ablation of anal high-grade dysplasia in men who have sex with men. Dis Colon Rectum 2011; 54 (10) 1284-1292
- 73 Chung AP, Rosenfeld DB. Intraoperative high-resolution anoscopy: a minimally invasive approach in the treatment of patients with Bowen's disease and results in a private practice setting. Am Surg 2007; 73 (12) 1279-1283
- 74 Factor SH, Cooperstein A, Pereira GA, Goldstone SE. Are colon and rectal surgeons ready to screen for anal dysplasia? Results of a survey on attitudes and practice. Sex Transm Dis 2014; 41 (04) 246-253
- 75 Palefsky JM. Practising high-resolution anoscopy. Sex Health 2012; 9 (06) 580-586
- 76 Taylor C, Munro AJ, Glynne-Jones R. , et al. Multidisciplinary team working in cancer: what is the evidence?. BMJ 2010; 340: c951
- 77 Renehan AG, O'Dwyer ST. Initial management through the anal cancer multidisciplinary team meeting. Colorectal Dis 2011; 13 (Suppl. 01) 21-28
- 78 Glynne-Jones R, Nilsson PJ, Aschele C. , et al; European Society for Medical Oncology (ESMO); European Society of Surgical Oncology (ESSO); European Society of Radiotherapy and Oncology (ESTRO). Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol 2014; 40 (10) 1165-1176
- 79 Eng C, Chang GJ, You YN. , et al. The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal. Oncotarget 2014; 5 (22) 11133-11142
- 80 Munro A, Brown M, Niblock P, Steele R, Carey F. Do multidisciplinary team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience. BMC Cancer 2015; 15: 686
- 81 Ye YJ, Shen ZL, Sun XT. , et al. Impact of multidisciplinary team working on the management of colorectal cancer. Chin Med J (Engl) 2012; 125 (02) 172-177